NYSCF Hosts Meeting of Health Research Alliance


This January, NYSCF hosted a regional meeting of the Health Research Alliance (HRA), a group of nonprofit research funders who are committed to maximizing the impact of biomedical research and improving human health.

The meeting featured a keynote address from Bruce R. Conway, PhD, Director of the Robertson Therapeutic Development Fund at The Rockefeller University, as well as a panel discussion on best practices for translational science featuring Dr. Conway, Michael L. Batten, MD, MBA, of the JDRF T1D Fund, Andres Hurtado-Lorenzo, PhD, Director of Translational Research at the Crohn’s & Colitis Foundation, Elizabeth Schwarzbach, PhD, Vice President of Business Development at NYSCF, and Caren A. Heller, MD, MBA, of the Crohn’s & Colitis Foundation.

The organizations in the HRA all share one goal: to make sure funded research will result in tangible benefits for patients. Last month’s meeting allowed attendees to discuss ways in which business practices can be used to achieve this goal. For example, the panel examined how partnering with industry and investing in research-based programs and products can ensure that therapies leave the lab and reach the bedside.

NYSCF is committed to fostering collaboration between researchers, industry, and other non-profits. Meetings of organizations like the HRA allow leaders in health and research to share ideas and identify ways to accelerate cures.

Learn more about HRA.